Michael A. Statnick

2.8k total citations
43 papers, 2.0k citations indexed

About

Michael A. Statnick is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Michael A. Statnick has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cellular and Molecular Neuroscience, 27 papers in Molecular Biology and 10 papers in Endocrine and Autonomic Systems. Recurrent topics in Michael A. Statnick's work include Neuropeptides and Animal Physiology (29 papers), Receptor Mechanisms and Signaling (23 papers) and Regulation of Appetite and Obesity (10 papers). Michael A. Statnick is often cited by papers focused on Neuropeptides and Animal Physiology (29 papers), Receptor Mechanisms and Signaling (23 papers) and Regulation of Appetite and Obesity (10 papers). Michael A. Statnick collaborates with scholars based in United States, Spain and United Kingdom. Michael A. Statnick's co-authors include Todd M. Suter, Donald R. Gehlert, Douglas A. Schober, D. Brooke Johnson, Robert A. Gadski, Matthias H. Tschöp, Magnus Berglund, Traci A. Czyzyk, Mark L. Heiman and Charles H. Mitch and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Physiology.

In The Last Decade

Michael A. Statnick

43 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Statnick United States	26	1.2k	980	580	567	214	43	2.0k
William T. Chance United States	28	934 0.8×	571 0.6×	495 0.9×	922 1.6×	113 0.5×	78	2.0k
Traci A. Czyzyk United States	18	582 0.5×	576 0.6×	436 0.8×	582 1.0×	79 0.4×	30	1.5k
Paul J. Emmerson United States	21	794 0.7×	833 0.8×	214 0.4×	460 0.8×	68 0.3×	34	1.7k
Florence Oury-Donat France	19	973 0.8×	841 0.9×	211 0.4×	426 0.8×	202 0.9×	25	2.0k
Jaw‐Kang Chang United States	24	1.5k 1.3×	1.3k 1.3×	238 0.4×	492 0.9×	39 0.2×	44	2.2k
Gábor Wittmann United States	28	369 0.3×	393 0.4×	1.0k 1.8×	601 1.1×	90 0.4×	71	2.4k
R. Steinberg France	27	1.9k 1.6×	1.6k 1.6×	197 0.3×	384 0.7×	66 0.3×	59	2.8k
M. Regina DeJoseph United States	18	590 0.5×	384 0.4×	222 0.4×	262 0.5×	115 0.5×	36	1.5k
Albert Sattin United States	22	1.0k 0.9×	792 0.8×	180 0.3×	243 0.4×	32 0.1×	61	2.0k
Ángel Manuel Carrión Spain	28	759 0.6×	1.3k 1.3×	122 0.2×	543 1.0×	77 0.4×	44	2.4k

Countries citing papers authored by Michael A. Statnick

Since Specialization

Citations

This map shows the geographic impact of Michael A. Statnick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Statnick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Statnick more than expected).

Fields of papers citing papers by Michael A. Statnick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Statnick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Statnick. The network helps show where Michael A. Statnick may publish in the future.

Co-authorship network of co-authors of Michael A. Statnick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Statnick. A scholar is included among the top collaborators of Michael A. Statnick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Statnick. Michael A. Statnick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nunn, Nicolas, David A. Bechtold, Todd M. Suter, et al.. (2022). The hypothalamic RFamide, QRFP, increases feeding and locomotor activity: The role of Gpr103 and orexin receptors. PLoS ONE. 17(10). e0275604–e0275604. 8 indexed citations

Kallupi, Marsida, Giulia Scuppa, Giordano de Guglielmo, et al.. (2016). Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction. Neuropsychopharmacology. 42(3). 695–706. 46 indexed citations

Eiler, William J.A., Yanyun Chen, Lawrence J. Slieker, et al.. (2016). Consequences of constitutive deletion of melanin-concentrating hormone-1 receptors for feeding and foraging behaviors of mice. Behavioural Brain Research. 316. 271–278. 4 indexed citations

Post, Anke, Trevor Smart, Gerard R. Dawson, et al.. (2015). A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies. Neuropsychopharmacology. 41(7). 1803–1812. 82 indexed citations

Toledo, Miguel A., Concepción Pedregal, Nuria Cirauqui, et al.. (2014). Discovery of a Novel Series of Orally Active Nociceptin/Orphanin FQ (NOP) Receptor Antagonists Based on a Dihydrospiro(piperidine-4,7′-thieno[2,3-c]pyran) Scaffold. Journal of Medicinal Chemistry. 57(8). 3418–3429. 49 indexed citations

Dodd, Garron T., Nicolas Nunn, David A. Bechtold, et al.. (2014). The Thermogenic Effect of Leptin Is Dependent on a Distinct Population of Prolactin-Releasing Peptide Neurons in the Dorsomedial Hypothalamus. Cell Metabolism. 20(4). 639–649. 97 indexed citations

Witkin, Jeffrey M., Michael A. Statnick, Linda M. Rorick‐Kehn, et al.. (2013). The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Pharmacology & Therapeutics. 141(3). 283–299. 160 indexed citations

Sindelar, Dana K., et al.. (2008). Activation of mesolimbic dopamine neurons during novel and daily limited access to palatable food is blocked by the opioid antagonist LY255582. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 295(2). R463–R471. 37 indexed citations

Need, Anne B., Jamie H. McKinzie, Charles H. Mitch, Michael A. Statnick, & Lee A. Phebus. (2007). In vivo rat brain opioid receptor binding of LY255582 assessed with a novel method using LC/MS/MS and the administration of three tracers simultaneously. Life Sciences. 81(17-18). 1389–1396. 33 indexed citations

10.

Shannon, Harlan E., Elizabeth L. Eberle, Charles H. Mitch, David L. McKinzie, & Michael A. Statnick. (2007). Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats. Neuropharmacology. 53(8). 930–941. 18 indexed citations

11.

Takeuchi, Kumiko, Jamie H. McKinzie, Todd M. Suter, et al.. (2007). Structure–activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1. Bioorganic & Medicinal Chemistry Letters. 17(19). 5349–5352. 9 indexed citations

12.

Cirauqui, Nuria, Mark J. Benvenga, Paul J. Emmerson, et al.. (2005). SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists. Bioorganic & Medicinal Chemistry Letters. 15(17). 3844–3848. 11 indexed citations

13.

Rodgers, George H., Jamie H. McKinzie, Todd M. Suter, et al.. (2003). Development of Displacement Binding and GTPγS Scintillation Proximity Assays for the Identification of Antagonists of the μ-Opioid Receptor. Assay and Drug Development Technologies. 1(5). 627–636. 9 indexed citations

14.

Berglund, Magnus, Douglas A. Schober, Michael A. Statnick, Patricia McDonald, & Donald R. Gehlert. (2003). The Use of Bioluminescence Resonance Energy Transfer 2 to Study Neuropeptide Y Receptor Agonist-Induced β-Arrestin 2 Interaction. Journal of Pharmacology and Experimental Therapeutics. 306(1). 147–156. 63 indexed citations

15.

Statnick, Michael A., Lisa S. Beavers, Helena Corominola, et al.. (2000). Decreased Expression Of apM1 in Omental and Subcutaneous Adipose Tissue of HumansWith Type 2 Diabetes. Journal of Diabetes Research. 1(2). 81–88. 178 indexed citations

16.

Statnick, Michael A., Douglas A. Schober, Susan L. Gackenheimer, et al.. (1998). Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites. Brain Research. 810(1-2). 16–26. 34 indexed citations

17.

Statnick, Michael A., Douglas A. Schober, Nancy G. Mayne, J. Paul Burnett, & Donald R. Gehlert. (1997). Analysis of NPY Receptor Subtypes in the Human Frontal Cortex Reveals Abundant Y1 mRNA and Binding Sites. Peptides. 18(1). 137–143. 10 indexed citations

18.

Statnick, Michael A., et al.. (1996). Neither intranigral fluoxetine nor 5,7-dihydroxytryptamine alter audiogenic seizures in genetically epilepsy-prone rats. European Journal of Pharmacology. 299(1-3). 93–102. 8 indexed citations

19.

Statnick, Michael A., et al.. (1996). Abnormalities in Brain Serotonin Concentration, High‐Affinity Uptake, and Tryptophan Hydroxylase Activity in Severe‐Seizure Genetically Epilepsy‐Prone Rats. Epilepsia. 37(4). 311–321. 48 indexed citations

20.

Lundell, Ingrid, Anders Blomqvist, Magnus Berglund, et al.. (1995). Cloning of a Human Receptor of the NPY Receptor Family with High Affinity for Pancreatic Polypeptide and Peptide YY. Journal of Biological Chemistry. 270(49). 29123–29128. 281 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact